Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Recruiting · NCT07091864 · Registry updated 2026-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not applicable | 2026-08-17 | NCT07091864 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Arizona | Phoenix | United States | 14 |
| Mayo Clinic in Florida | Jacksonville | United States | 89 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |